Novo Nordisk India's managing director Vikrant Shrotriya told Financial Express he sees steady growth even as cheaper generics move in, per Investseekers.
Recap by typeshit. Post by Investseekers on X.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
Six peptides including BPC-157 and TB-500 won advisory panel votes, but Martin notes compounding them stays unlawful until the FDA finalizes the bulks list.
NYU Langone obesity specialist Babak Orandi says there's no evidence these powders raise GLP-1 levels. The smoothie add-on cost $30 with tip.
Loading…